Showing results (11-20 of 721) with videos related to
Sort By:
Pageof 73
European Journal of Neurology|December 5, 2002
The basis for day and night-time control of symptoms of Parkinson's diseaseK Ray ChaudhuriExpert Opinion on Drug Safety|February 21, 2015
Safety of IPX066 , an extended release carbidopa-levodopa formulation, for the treatment of Parkinson's diseaseMeir Kestenbaum, Stanley FahnCNS Drugs|July 13, 2015
Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's DiseaseDaphne Robakis, Stanley FahnCold Spring Harbor Perspectives in Medicine|September 22, 2025
Parkinson's Disease, Second EditionSerge Przedborski, Stanley FahnCurrent Neurology and Neuroscience Reports|June 5, 2012
Botulinum toxin for the treatment of movement disordersMary Ann Thenganatt, Stanley FahnNeurology|April 6, 2016
Levodopa therapy for Parkinson disease: A look backward and forwardPeter A LeWitt, Stanley FahnNeurosurgical Focus|March 17, 2005
Status of fetal tissue transplantation for the treatment of advanced Parkinson diseasePaul E Greene, Stanley FahnInternational Review of Neurobiology|August 15, 2017
Palliative Care and Nonmotor Symptoms in Parkinson's Disease and ParkinsonismNataliya Titova, K Ray ChaudhuriInternational Review of Neurobiology|August 15, 2017
Personalized Medicine and Nonmotor Symptoms in Parkinson's DiseaseNataliya Titova, K Ray ChaudhuriExpert Review of Neurotherapeutics|April 14, 2017
Intrajejunal levodopa infusion therapy for Parkinson's disease: practical and pragmatic tips for successful maintenance of therapyNataliya Titova, K Ray ChaudhuriPageof 73